Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Assets Average (2016 - 2025)

Amphastar Pharmaceuticals has reported Assets Average over the past 12 years, most recently at $1.6 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.6 billion for Q4 2025, up 5.54% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (up 5.54% YoY), and the annual figure for FY2025 was $1.6 billion, up 3.77%.
  • Assets Average for Q4 2025 was $1.6 billion at Amphastar Pharmaceuticals, roughly flat from $1.6 billion in the prior quarter.
  • Over the last five years, Assets Average for AMPH hit a ceiling of $1.6 billion in Q4 2025 and a floor of $638.5 million in Q1 2021.
  • Median Assets Average over the past 5 years was $1.3 billion (2023), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Assets Average: skyrocketed 108.18% in 2023 and later increased 2.13% in 2024.
  • Amphastar Pharmaceuticals' Assets Average stood at $661.6 million in 2021, then rose by 10.99% to $734.3 million in 2022, then skyrocketed by 108.18% to $1.5 billion in 2023, then rose by 2.13% to $1.6 billion in 2024, then grew by 5.54% to $1.6 billion in 2025.
  • The last three reported values for Assets Average were $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.